CURTIS: Clinical Unit for Research Trials & Outcomes in Skin
Clinical trials at CURTIS, also known as Harvard Skin Studies, conducts patient studies for a broad spectrum of skin conditions.
CURTIS stands for the Clinical Unit for Research Trials and Outcomes in Skin. We are a research unit in the Dermatology Department of Massachusetts General Hospital that conducts a wide range of patient studies evaluating new therapies for a broad spectrum of skin diseases as well as investigating quality of life issues. Our unit also offers cutting-edge therapy to patients looking for alternative or new approaches to care.
Also known as Harvard Skin Studies, CURTIS performs investigator-initiated studies as well as industry-sponsored clinical studies from Phase 1 through Phase 4. Our physicians, faculty, residents and fellows have broad expertise and experience on a wide range of dermatologic conditions.
Our faculty serve as principal investigators, and our dermatology residents and postdoctoral fellow can participate with faculty to design and perform clinical research as part of their training.
Maria B. Alora, MD, the Director of CURTIS, manages clinical trials evaluating new therapies and devices for a broad spectrum of skin diseases including psoriasis, hidradenitis suppurativa, alopecia, atopic dermatitis, warts, rosacea, acne, and skin aging.
As part of the Harvard Medical School and Mass General Brigham, our dermatology research unit has been conducting clinical studies for more than 30 years.
The first step in the process is to contact us at firstname.lastname@example.org. Our scheduler can outline the trial criteria, risks, and benefits for you. If you feel you meet the initial criteria and want to participate in the study:
All appointments are at 50 Staniford Street, Suite 240 Boston, MA